Between Doximity and Veeva Systems, Which Stock Looks Set to Break Out?

VEEV: Veeva Systems logo
VEEV
Veeva Systems

Veeva Systems fell -17% during the past Month. You may be tempted to buy more, or may want to reduce your exposure. But there is an entirely different perspective you might be missing. Is there a better alternative? Turns out, its peer Doximity gives you more. Doximity (DOCS) stock offers superior revenue growth across key periods, better profitability, and relatively lower valuation vs Veeva Systems (VEEV) stock, suggesting you may be better off investing in DOCS

  • DOCS’s quarterly revenue growth was 23.2%, vs. VEEV’s 16.0%.
  • In addition, its Last 12 Months revenue growth came in at 20.2%, ahead of VEEV’s 16.0%.
  • DOCS leads on profitability over both periods – LTM margin of 39.7% and 3-year average of 36.9%.

These differences become even clearer when you look at the financials side by side. The table highlights how VEEV’s fundamentals stack up against those of DOCS on growth, margins, momentum, and valuation multiples.

Valuation & Performance Overview

  VEEV DOCS Preferred
     
Valuation      
P/EBIT Ratio 42.7 34.2 DOCS
     
Revenue Growth      
Last Quarter 16.0% 23.2% DOCS
Last 12 Months 16.0% 20.2% DOCS
Last 3 Year Average 14.1% 17.4% DOCS
     
Operating Margins      
Last 12 Months 27.9% 39.7% DOCS
Last 3 Year Average 23.2% 36.9% DOCS
     
Momentum      
Last 3 Year Return 36.3% 28.7% VEEV

Note: For “Last 3 Year Return” metric, preferred stock is one with higher returns unless the returns are too high (>300%) which creates risk of sell off.
See more revenue details: VEEV Revenue Comparison | DOCS Revenue Comparison
See more margin details: VEEV Operating Income Comparison | DOCS Operating Income Comparison

Relevant Articles
  1. How to Get Paid to Buy META at a Steep Discount
  2. Triggers That Could Ignite the Next Rally In Palantir Technologies Stock
  3. Why Amazon.com Stock May Drop Soon
  4. Webull Stock: Strong Cash Flow Poised for a Re-Rating?
  5. High Margins, 44% Discount: Buy Visa Stock Now
  6. Lowe’s Companies Stock Hands $76 Bil Back – Worth a Look?

See detailed fundamentals on Buy or Sell DOCS Stock and Buy or Sell VEEV Stock. Below we compare market return and related metrics across years.

Historical Market Performance

  2020 2021 2022 2023 2024 2025 Total [1] Avg Best
Returns
VEEV Return 94% -6% -37% 19% 9% 6% 58%    
DOCS Return -33% -16% 90% -18%   <===
S&P 500 Return 16% 27% -19% 24% 23% 17% 113%  
Monthly Win Rates [3]
VEEV Win Rate 67% 58% 33% 50% 58% 50%   53%  
DOCS Win Rate 33% 25% 50% 67% 42%   <===
S&P 500 Win Rate 58% 75% 42% 67% 75% 73%   65%  
Max Drawdowns [4]
VEEV Max Drawdown -14% -11% -41% -2% -11% -0%   -13%  
DOCS Max Drawdown -52% -41% -18% -19%   <===
S&P 500 Max Drawdown -31% -1% -25% -1% -2% -15%   -12%  

[1] Cumulative total returns since the beginning of 2020
[2] 2025 data is for the year up to 12/22/2025 (YTD)
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year

No matter how good the numbers, stock investment is never a smooth ride. There is a risk you must factor in. Read DOCS Dip Buyer Analyses and VEEV Dip Buyer Analyses to see how these stocks have fallen and recovered in the past.

Still not sure about VEEV or DOCS? Consider portfolio approach.

Portfolios Are The Smarter Way To Invest

Individual stocks can soar or tank but one thing matters: staying invested. The right portfolio can help you stay invested, capture upside and mitigate the downside associated with any individual stock.

The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.